NICE recommends three type 2 diabetes treatments
25 May 2016 | By Victoria White, Digital Content Producer
NICE has published final guidance recommending three drugs for treating type 2 diabetes: canagliflozin, dapagliflozin and empagliflozin...
List view / Grid view
News
New data for vedolizumab in UC presented at DDW
24 May 2016 | By Victoria White, Digital Content Producer
Vedolizumab is the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active UC...
Lariam only to be considered as a last resort, says Defence Committee
24 May 2016 | By Victoria White, Digital Content Producer
Lariam, the anti-malarial drug sometimes prescribed to British troops, should be considered only as a drug of last resort, says the Defence Committee...
New data show clinical benefit of Adacolumn in UC
24 May 2016 | By Victoria White, Digital Content Producer
Prof. Dr. Axel Dignass said the data show that Adacolumn provided clinical benefit in steroid-dependent patients with UC with previous failure to biologics...
Champix label updated to include new safety and efficacy data
24 May 2016 | By Victoria White, Digital Content Producer
As part of the update, the black triangle symbol, indicating that additional safety monitoring for Champix in the UK was required, has been removed...
EC grants conditional approval to daratumumab in multiple myeloma
23 May 2016 | By Victoria White, Digital Content Producer
Daratumumab is the first CD38-directed mAb approved in Europe. It binds to CD38, a signalling molecule expressed on the surface of multiple myeloma cells...
Helperby’s new approach to fighting resistant bacteria
23 May 2016 | By Victoria White, Digital Content Producer
Helperby is about to begin clinical studies of a completely new approach to fighting resistant bacteria following a positive meeting with the FDA...
Parkinson’s disease therapy safinamide launches in the UK
23 May 2016 | By Victoria White, Digital Content Producer
Commenting on the launch, Maurizio Castorina, CEO of Zambon, said safinamide offers PD patients "a novel therapeutic option"...
Eurasian operations and production strategies examined at CPhI Russia and CPhI South East Asia
23 May 2016 | By CPhI
UBM EMEA, leading organisers of CPhI Russia and CPhI South East Asia, provide an Asia trends update following the closing of its events...
L.B. Bohle Installs BFC 600 in India
20 May 2016 | By L.B. Bohle Maschinen + Verfahren GmbH,
Sales Office relocates from Goa to the metropolis of Mumbai...
Long term benefits of breast cancer drug pertuzumab too uncertain says NICE
20 May 2016 | By Katie Sadler
NICE has announced it will not be recommending pertuzumab to treat HER2-positive breast cancer because it is uncertain of the long term benefits for patients.
Study reveals Alecensa is effective against specific type of lung cancer in Japanese patients
20 May 2016 | By Katie Sadler
Roche has announced that Alecensa, an oral anaplastic lymphoma kinase (ALK) inhibitor, reduced the risk of disease worsening or death in Japanese people with advanced or recurrent, ALK-positive non-small cell lung cancer (NSCLC).
Research organisation calls for urgent action to tackle obesity
19 May 2016 | By Katie Sadler
The European Association for the Study of Obesity (EASO) has issued a warning urging for action to tackle the regions rising obesity epidemic.
Tiotropium found to improve lung function of children with asthma
18 May 2016 | By Katie Sadler
New data has revealed tiotropium improves lung function in children who continue to experience asthma symptoms despite taking other maintenance therapies.
Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome
18 May 2016 | By Mandy Parrett, Editorial Assistant
Biopharmaceutical company, Newron, has announced that its Investigational New Drug (IND) application to evaluate Sarizotan in treatment of Rett Syndrome has been approved by the FDA.
